BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23030810)

  • 1. A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: implications for PSA testing.
    Forbat L; Place M; Kelly D; Hubbard G; Boyd K; Howie K; Leung HY
    BJU Int; 2013 Mar; 111(3):389-95. PubMed ID: 23030810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
    Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
    Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior.
    McDowell ME; Occhipinti S; Chambers SK
    Health Psychol; 2013 Nov; 32(11):1158-69. PubMed ID: 23527518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of US and Australian men's values and preferences for PSA screening.
    Howard K; Brenner AT; Lewis C; Sheridan S; Crutchfield T; Hawley S; Nielsen ME; Pignone MP
    BMC Health Serv Res; 2013 Oct; 13():388. PubMed ID: 24093428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.
    Kirkegaard P; Edwards A; Nielsen TLO; Ørntoft TF; Sørensen KD; Borre M; Bro F
    BMC Fam Pract; 2018 Feb; 19(1):32. PubMed ID: 29454309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Men's knowledge about prostate cancer: a case study of rural Mhondoro-Ngezi, Kadoma District, Zimbabwe.
    Moyo S
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 28111857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
    Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
    BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
    Avery KN; Metcalfe C; Vedhara K; Lane JA; Davis M; Neal DE; Hamdy FC; Donovan JL; Blazeby JM
    Eur Urol; 2012 Oct; 62(4):649-55. PubMed ID: 22244151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family history, perceived risk, and prostate cancer screening among African American men.
    Bloom JR; Stewart SL; Oakley Girvan I; Banks PJ; Chang S
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2167-73. PubMed ID: 17119042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing Nigerian men's decision to undergo prostate specific antigen testing.
    Enaworu OU; Khutan R
    Afr Health Sci; 2016 Jun; 16(2):524-32. PubMed ID: 27605968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific antigen testing in family practice: a cross sectional survey of self-reported rates of and reasons for testing participation and risk disclosure.
    Carey M; Bryant J; Yoong SL; Russell G; Barker D; Sanson-Fisher R
    BMC Fam Pract; 2013 Dec; 14():186. PubMed ID: 24321004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
    McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
    BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review.
    Kinsella N; Stattin P; Cahill D; Brown C; Bill-Axelson A; Bratt O; Carlsson S; Van Hemelrijck M
    Eur Urol; 2018 Sep; 74(3):261-280. PubMed ID: 29598981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing men's decisions regarding prostate cancer screening: a qualitative study.
    Ferrante JM; Shaw EK; Scott JG
    J Community Health; 2011 Oct; 36(5):839-44. PubMed ID: 21336996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific antigen testing is associated with men's psychological and physical health and their healthcare utilisation in a nationally representative sample: a cross-sectional study.
    Flahavan EM; Drummond FJ; Bennett K; Barron TI; Sharp L
    BMC Fam Pract; 2014 Jun; 15():121. PubMed ID: 24938184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
    Macefield RC; Lane JA; Metcalfe C; Down L; Neal DE; Hamdy FC; Donovan JL
    Eur J Cancer; 2009 Sep; 45(14):2569-73. PubMed ID: 19375907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interpersonal relationships in men's attendance in primary care: qualitative findings in a cohort of men with prostate cancer.
    Forbat L; Place M; Hubbard G; Leung H; Kelly D
    Support Care Cancer; 2014 Feb; 22(2):409-15. PubMed ID: 24197054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
    Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
    BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Younger British men's understandings of prostate cancer: A qualitative study.
    Grogan S; Parlane VL; Buckley E
    J Health Psychol; 2017 May; 22(6):743-753. PubMed ID: 26537520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.